{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:07:57Z","timestamp":1791806877073,"version":"4.3.4"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T00:00:00Z","timestamp":1644537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31930020, 81870488, 81521004, 81530048"],"award-info":[{"award-number":["31930020, 81870488, 81521004, 81530048"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20170142"],"award-info":[{"award-number":["BK20170142"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["2018PT31043, 2019PT320015"],"award-info":[{"award-number":["2018PT31043, 2019PT320015"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The evaluation of the nodal status of hepatocellular carcinoma (HCC) is a classic but controversial topic. This study aimed to investigate the incidence of lymph node metastasis (LNM), explore the role of lymph node dissection (LND), and develop and validate a novel model to predict LNM in patients with HCC, not other specified (NOS).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The study cohort was taken from the Surveillance, Epidemiology, and End Results database. The annual percent change (APC) was calculated using the Joinpoint regression. Survival analyses adopted the competing risk model. The nomogram was constructed based on the least absolute shrinkage and selection operator (LASSO) logistic regression algorithm and validated by calibration curves. The area under the receiver operating characteristic curve (AUROC) was obtained to compare prognostic performance. Decision curve and clinical impact curve analyses were introduced to examine the clinical value of the models.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 8,829 patients were finally enrolled in this study, and 1,346 (15.2%) patients received LND. The LND rate showed no noticeable fluctuation in the last decade, with an APC of 0.5% (P=0.593). LNM was identified in 56 (4.2%) patients and confirmed an independent prognostic factor of HCC patients (P=0.005). There were 2,497 lymph nodes retrieved, and 93 (3.7%) of them were positive. After propensity score matching, LND indicated no direct oncologic benefit and did not worsen competing risks. Moreover, an increased number of lymph nodes retrieved could not improve prognoses. 1,346 patients with LND were further randomly divided into the training and validation sets with the ratio of 1:1. Race, tumor size, clinical T stage, extrahepatic bile duct invasion, and tumor grade were independent risk factors for LNM. The constructed model was well calibrated and showed good discrimination power and net benefits in clinical practice.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>LNM is an independent prognostic factor in HCC, but routine LND seems to be unnecessary in HCC patients. The constructed model could predict the presence of LNM in HCC patients with good performance, which is meaningful to patient stratification and individual treatment strategies optimization.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2022.835957","type":"journal-article","created":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T09:47:02Z","timestamp":1644572822000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["Development and Validation of a Novel Model to Predict Regional Lymph Node Metastasis in Patients With Hepatocellular Carcinoma"],"prefix":"10.3389","volume":"12","author":[{"given":"Xiaoyuan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoyong","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuehao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer Statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.2147\/JHC.S321346","article-title":"Liver Cancer Survival: A Real World Observation of 45 Years With 32,556 Cases","volume":"8","author":"Chen","year":"2021","journal-title":"J Hepatocell Carcinoma"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.2147\/JHC.S320172","article-title":"Machine Learning to Improve Prognosis Prediction of Early Hepatocellular Carcinoma After Surgical Resection","volume":"8","author":"Ji","year":"2021","journal-title":"J Hepatocell Carcinoma"},{"key":"B4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3760\/cma.j.cn112139-20201110-00791","article-title":"Surgical Treatment of Primary Liver Cancer:a Report of 10 966 Cases","volume":"59","author":"Xia","year":"2021","journal-title":"Zhonghua Wai Ke Za Zhi"},{"key":"B5","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1053\/j.gastro.2018.08.065","article-title":"Epidemiology and Management of Hepatocellular Carcinoma","volume":"156","author":"Kulik","year":"2019","journal-title":"Gastroenterology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3760\/cma.j.issn.1673-9752.2020.01.001","article-title":"Standardization for Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition)","volume":"19","year":"2020","journal-title":"Chin J Dig Surg"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2020.06.035","article-title":"Fibrolamellar Carcinoma: Challenging the Challenge","volume":"137","author":"Lamarca","year":"2020","journal-title":"Eur J Cancer"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.21147\/j.issn.1000-9604.2018.03.08","article-title":"Clinicopathological Features and Surgical Outcomes of Four Rare Subtypes of Primary Liver Carcinoma","volume":"30","author":"Li","year":"2018","journal-title":"Chin J Cancer Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v13.i3.414","article-title":"Clinical Features and Prognosis of Patients With Extrahepatic Metastases From Hepatocellular Carcinoma","volume":"13","author":"Uka","year":"2007","journal-title":"World J Gastroenterol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.21037\/apm-20-1876","article-title":"A Practical Nomogram From the SEER Database to Predict the Prognosis of Hepatocellular Carcinoma in Patients With Lymph Node Metastasis","volume":"10","author":"Zhang","year":"2021","journal-title":"Ann Palliat Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.suronc.2020.12.011","article-title":"Lymph Node Sampling in Resectable Hepatocellular Carcinoma: National Practice Patterns and Predictors of Positive Lymph Nodes","volume":"36","author":"Kemp Bohan","year":"2021","journal-title":"Surg Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/1710670","article-title":"A Noninvasive Prediction Nomogram for Lymph Node Metastasis of Hepatocellular Carcinoma Based on Serum Long Noncoding RNAs","volume":"2019","author":"Ma","year":"2019","journal-title":"BioMed Res Int"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-019-08071-7","article-title":"Integrated Nomograms for Preoperative Prediction of Microvascular Invasion and Lymph Node Metastasis Risk in Hepatocellular Carcinoma Patients","volume":"27","author":"Yan","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e31828d4960","article-title":"Impact of Histologically Confirmed Lymph Node Metastases on Patient Survival After Surgical Resection for Hepatocellular Carcinoma: Report of a Japanese Nationwide Survey","volume":"259","author":"Hasegawa","year":"2014","journal-title":"Ann Surg"},{"key":"B15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S1015-9584(11)60020-1","article-title":"Hepatic Resection for Hepatocellular Carcinoma With Lymph Node Metastasis: Clinicopathological Analysis and Survival Outcome","volume":"34","author":"Lee","year":"2011","journal-title":"Asian J Surg"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-010-0400-0","article-title":"Clinical Significance of Lymph Node Metastasis in Patients Undergoing Partial Hepatectomy for Hepatocellular Carcinoma","volume":"34","author":"Shen","year":"2010","journal-title":"World J Surg"},{"key":"B17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/jso.20772","article-title":"Incidence and Prognostic Values of Lymph Node Metastasis in Operable Hepatocellular Carcinoma and Evaluation of Routine Complete Lymphadenectomy","volume":"96","author":"Sun","year":"2007","journal-title":"J Surg Oncol"},{"key":"B18","article-title":"Primary Liver Cancer in Japan. Clinicopathologic Features and Results of Surgical Treatment","volume":"211","year":"1990","journal-title":"Ann Surg"},{"key":"B19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1055\/s-0030-1247133","article-title":"Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects","volume":"30","author":"Forner","year":"2010","journal-title":"Semin Liver Dis"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpedsurg.2013.05.007","article-title":"Hepatocellular Carcinoma in Children: Epidemiology and the Impact of Regional Lymphadenectomy on Surgical Outcomes","volume":"48","author":"McAteer","year":"2013","journal-title":"J Pediatr Surg"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s00534-011-0372-y","article-title":"Surgical Treatment of Lymph Node Metastases From Hepatocellular Carcinoma","volume":"18","author":"Kobayashi","year":"2011","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000109154.00020.e0","article-title":"The Role of Lymphadenectomy for Liver Tumors: Further Considerations on the Appropriateness of Treatment Strategy","volume":"239","author":"Ercolani","year":"2004","journal-title":"Ann Surg"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000000277","article-title":"Hepatectomy Versus Hepatectomy With Lymphadenectomy in Hepatocellular Carcinoma: A Prospective, Randomized Controlled Clinical Trial","volume":"49","author":"Wu","year":"2015","journal-title":"J Clin Gastroenterol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-014-2667-1","article-title":"Management of Lymph Nodes During Resection of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: A Systematic Review","volume":"18","author":"Amini","year":"2014","journal-title":"J Gastrointest Surg"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000217606.59625.9d","article-title":"Perihepatic Lymph Node Assessment in Patients Undergoing Partial Hepatectomy for Malignancy","volume":"244","author":"Grobmyer","year":"2006","journal-title":"Ann Surg"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-0713","article-title":"X-Tile: A New Bio-Informatics Tool for Biomarker Assessment and Outcome-Based Cut-Point Optimization","volume":"10","author":"Camp","year":"2004","journal-title":"Clin Cancer Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z","article-title":"Permutation Tests for Joinpoint Regression With Applications to Cancer Rates","volume":"19","author":"Kim","year":"2000","journal-title":"Stat Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X06295361","article-title":"Decision Curve Analysis: A Novel Method for Evaluating Prediction Models","volume":"26","author":"Vickers","year":"2006","journal-title":"Med Decis Making"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.21037\/atm-21-2785","article-title":"Evaluation of Nodal Status in Intrahepatic Cholangiocarcinoma: A Population-Based Study","volume":"9","author":"Chen","year":"2021","journal-title":"Ann Transl Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/3002480","article-title":"Morbidity, Prognostic Factors, and Competing Risk Nomogram for Combined Hepatocellular-Cholangiocarcinoma","volume":"2021","author":"Chen","year":"2021","journal-title":"J Oncol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.21037\/apm.2019.11.17","article-title":"Image-Guided Intensity-Modulated Radiotherapy Improves Short-Term Survival for Abdominal Lymph Node Metastases From Hepatocellular Carcinoma","volume":"8","author":"Zhang","year":"2019","journal-title":"Ann Palliat Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1080\/02656736.2018.1542510","article-title":"Safety and Technical Feasibility of Percutaneous Ablation for Lymph Node Metastases of Hepatocellular Carcinoma","volume":"36","author":"Yuan","year":"2019","journal-title":"Int J Hyperthermia"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2016151807","article-title":"Percutaneous CT-Guided Radiofrequency Ablation for Lymph Node Oligometastases From Hepatocellular Carcinoma: A Propensity Score-Matching Analysis","volume":"282","author":"Pan","year":"2017","journal-title":"Radiology"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/jso.23994","article-title":"Transcatheter Arterial Chemoembolization (TACE) for Lymph Node Metastases in Patients With Hepatocellular Carcinoma","volume":"112","author":"Wu","year":"2015","journal-title":"J Surg Oncol"},{"key":"B35","article-title":"Lymphadenectomy Combined With Locoregional Treatment for Multiple Advanced Hepatocellular Carcinoma With Lymph Node Metastases","volume":"59","author":"Awazu","year":"2013","journal-title":"Kobe J Med Sci"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/ans.15096","article-title":"Prevalence and Clinical Significance of Regional Lymphadenectomy in Patients With Hepatocellular Carcinoma","volume":"89","author":"Yang","year":"2019","journal-title":"ANZ J Surg"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v25.i16.1986","article-title":"Dual Energy Computed Tomography for Detection of Metastatic Lymph Nodes in Patients With Hepatocellular Carcinoma","volume":"25","author":"Zeng","year":"2019","journal-title":"World J Gastroenterol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.13244","article-title":"Clinicopathological and Prognostic Significance of Platelet-to-Lymphocyte Ratio in Patients With Hepatocellular Carcinoma","volume":"7","author":"Song","year":"2016","journal-title":"Oncotarget"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.6534","article-title":"A microRNA-Based Prediction Model for Lymph Node Metastasis in Hepatocellular Carcinoma","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-020-04769-z","article-title":"Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET\/CT for the Diagnosis of Primary and Metastatic Lesions in Patients With Various Types of Cancer","volume":"47","author":"Chen","year":"2020","journal-title":"Eur J Nucl Med Mol Imag"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.835957\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T09:47:07Z","timestamp":1644572827000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2022.835957\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,11]]},"references-count":40,"alternative-id":["10.3389\/fonc.2022.835957"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2022.835957","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,11]]},"article-number":"835957"}}